NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Mahindra & Mahindra Sees 20-Fold Increase in Patents Granted

Mahindra & Mahindra has reported a significant milestone in its innovation journey, with a 20-fold increase in patents granted between FY16 and FY26. The company has seen a substantial growth in its patent portfolio, with 1,334 patents granted in FY26, compared to just 56 in FY16.

The cumulative patent applications filed by Mahindra & Mahindra stood at 2,728 as of March 2026. This impressive growth is a testament to the company's commitment to innovation and research and development. Breaking down the granted patents, Mahindra & Mahindra has allocated 60% of its patent portfolio to the automotive business, while the remaining 40% pertains to its Farm Business.

It is worth noting that the patent portfolio also includes filings made by M&M's subsidiary, Mahindra Electric Automobile Ltd. This diversification of intellectual property across different business segments highlights the company's strategic approach to innovation and its willingness to invest in emerging technologies.

Read also: Oshea Herbals Aims for Rs 650 Crore Revenue Amidst Expansion Efforts

YearPatents Granted
FY1656
FY261,334
Growth20-fold

This growth in patents granted is a significant achievement for Mahindra & Mahindra and underscores its position as a leader in innovation and technology. The company's focus on research and development is expected to continue, driving growth and competitiveness in the market.

Investor Takeaway

Investors should expect Mahindra & Mahindra to continue innovating and expanding its patent portfolio.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.